prednisone has been researched along with Aggressive Systemic Mastocytosis in 15 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Aggressive Systemic Mastocytosis: A form of systemic mastocytosis in which patients have impaired organ functions due to multifocal infiltrates of pathological MAST CELLS in bone marrow, liver, spleen, gastrointestinal tract, or skeletal system. The cytomorphology shows a low to high grade.
Excerpt | Relevance | Reference |
---|---|---|
" The combination of IFN-alpha and hydroxyurea is very useful and allows dosage reduction of IFN-alpha and better control of hypereosinophilia than with either agent alone." | 2.43 | Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis. ( Butterfield, JH, 2005) |
"Our case is the first published case of exophthalmos and eyelid edema associated with systemic mastocytosis confirmed by pathologic examination of periocular biopsies that was treated effectively with cladribine." | 1.43 | Exophthalmos, Diplopia, and Bilateral Eyelid Edema: Symptoms of Ocular Mastocytosis. ( Canioni, D; Chandesris, O; Costes, V; Frouin, E; Menjot de Champfleur, N; Mura, F; Payerols, A; Schiffmann, A; Villain, M, 2016) |
"We report two unusual cases of acquired aplastic anemia (AA) in which multifocal aggregates of bone marrow mast cells fulfilled morphologic and immunophenotypic criteria for SM according to the World Health Organization 2008 classification." | 1.40 | Two cases of concomitant acquired aplastic anemia and systemic mastocytosis. ( Czuchlewski, DR; George, TI; Golardi, N; Myers, JB; Saffer, H; Sramek, JE, 2014) |
"Systemic mastocytosis is a rare and occasionally aggressive condition that raises major diagnostic challenges." | 1.32 | Aggressive systemic mastocytosis. ( Bertin, P; Inaoui, R; Jaccard, A; Petit, B; Trèves, R, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (53.33) | 29.6817 |
2010's | 7 (46.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, C | 1 |
Greenberger, PA | 1 |
Papadopoulou, V | 1 |
Ioannou, S | 1 |
Levidou, G | 1 |
Variami, E | 1 |
Kouzis, P | 1 |
Siakantaris, M | 1 |
Golardi, N | 1 |
Sramek, JE | 1 |
Myers, JB | 1 |
Saffer, H | 1 |
George, TI | 1 |
Czuchlewski, DR | 1 |
Payerols, A | 1 |
Frouin, E | 1 |
Schiffmann, A | 1 |
Menjot de Champfleur, N | 1 |
Canioni, D | 1 |
Chandesris, O | 1 |
Costes, V | 1 |
Villain, M | 1 |
Mura, F | 1 |
Prabhakaran, A | 1 |
Dhaliwal, G | 1 |
Schilf, CR | 1 |
Caughey, GH | 1 |
Pile, J | 1 |
Eccersley, LR | 1 |
Hoffbrand, AV | 1 |
Rustin, MH | 1 |
McNamara, CJ | 1 |
Lamm, CG | 1 |
Stern, AW | 1 |
Smith, AJ | 1 |
Cooper, EJ | 1 |
Ullom, SW | 1 |
Campbell, GA | 1 |
Lim, KH | 1 |
Pardanani, A | 1 |
Butterfield, JH | 2 |
Li, CY | 1 |
Tefferi, A | 1 |
Ross, JJ | 1 |
Saavedra, A | 1 |
Vleugels, RA | 1 |
Liu, A | 1 |
Castells, MC | 1 |
Liu, AY | 1 |
Lowe, RC | 1 |
Levy, BD | 1 |
Katz, JT | 1 |
Loscalzo, J | 1 |
Inaoui, R | 1 |
Petit, B | 1 |
Jaccard, A | 1 |
Bertin, P | 1 |
Trèves, R | 1 |
Tolar, J | 1 |
Tope, WD | 1 |
Neglia, JP | 1 |
Marbello, L | 1 |
Anghilieri, M | 1 |
Nosari, A | 1 |
Minola, E | 1 |
Cairoli, R | 1 |
Ricci, F | 1 |
Morra, E | 1 |
Hein, MS | 1 |
Hansen, L | 1 |
4 reviews available for prednisone and Aggressive Systemic Mastocytosis
Article | Year |
---|---|
Idiopathic anaphylaxis.
Topics: Anaphylaxis; Diagnosis, Differential; Epinephrine; Humans; Mastocytosis, Systemic; Prednisone | 2019 |
A shocking diagnosis.
Topics: Acetates; Aged; Anti-Inflammatory Agents; Cyclopropanes; Diagnosis, Differential; Humans; Hypotensio | 2017 |
Aggressive systemic mastocytosis: a case report and brief review of the literature.
Topics: Aged; Antineoplastic Agents, Hormonal; Biopsy; Bone Marrow Cells; Clinical Chemistry Tests; Diagnosi | 2005 |
Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Movement; Cell Prolifera | 2005 |
11 other studies available for prednisone and Aggressive Systemic Mastocytosis
Article | Year |
---|---|
Systemic mastocytosis accompanied by a non-secretory plasma cell dyscrasia and nephrotic syndrome-level proteinuria in a 76-year-old patient.
Topics: Aged; Amyloidosis; Anemia; Biopsy; Bone Marrow; Clone Cells; Coloring Agents; Congo Red; Darbepoetin | 2014 |
Two cases of concomitant acquired aplastic anemia and systemic mastocytosis.
Topics: Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Cells; Bone Marrow Examination; Cyclosporine; Hu | 2014 |
Exophthalmos, Diplopia, and Bilateral Eyelid Edema: Symptoms of Ocular Mastocytosis.
Topics: Administration, Oral; Diplopia; Edema; Exophthalmos; Eyelid Diseases; Glucocorticoids; Humans; Infus | 2016 |
Paraneoplastic pemphigus associated with systemic mastocytosis.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cladribine; Disease Progres | 2009 |
Disseminated cutaneous mast cell tumors with epitheliotropism and systemic mastocytosis in a domestic cat.
Topics: Animals; Anti-Bacterial Agents; Cats; Exons; Female; Fetus; Mast Cells; Mastocytosis; Mastocytosis, | 2009 |
Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine.
Topics: Adult; Aged; Aged, 80 and over; Benzamides; Bone Marrow; Cladribine; Dioxygenases; DNA Mutational An | 2009 |
Interactive medical case. A rash hypothesis.
Topics: Acetates; Adult; Anti-Inflammatory Agents; Cromolyn Sodium; Cyclopropanes; Diarrhea; Drug Therapy, C | 2010 |
Clinical problem-solving. A rash hypothesis.
Topics: Adult; Biopsy; Blood Cell Count; Bone Marrow; Colon; Diagnosis, Differential; Diarrhea; Drug Therapy | 2010 |
Aggressive systemic mastocytosis.
Topics: Aged; Alendronate; Bone Marrow Cells; Fatal Outcome; Female; Humans; Interferon-alpha; Leukemia, Mye | 2003 |
Leukotriene-receptor inhibition for the treatment of systemic mastocytosis.
Topics: Acetates; Anti-Inflammatory Agents; Cyclopropanes; Drug Therapy, Combination; Humans; Infant; Leukot | 2004 |
Aggressive systemic mastocytosis mimicking sclerosing cholangitis.
Topics: Abdominal Pain; Adrenal Cortex Hormones; Adult; Amino Acid Substitution; Antineoplastic Combined Che | 2004 |